The Plexus Worldwide lawsuit and regulatory record includes a $600,000 Department of Justice settlement over postal fraud, a Food and Drug Administration warning letter about disease claims on three supplements, multiple Federal Trade Commission actions covering COVID-19 marketing and income claims, and a California settlement over lead in its products. Plexus is an Arizona-based multilevel marketing company that sells nutritional supplements and personal care products, and the actions below span roughly a decade.
The $600,000 DOJ Postal Fraud Settlement
On July 28, 2023, Plexus agreed to pay $600,000 to resolve U.S. Department of Justice allegations that it violated the False Claims Act in the way it mailed packages through the U.S. Postal Service.1U.S. Department of Justice. Plexus Worldwide LLC Agrees to Pay $600,000 to Resolve Alleged False Claims Violations The government said Plexus calculated postage using incorrect package attributes, including understated weights, and reused duplicate postage on outgoing shipments, producing systematic underpayments to the Postal Service.
Plexus admitted as part of the settlement that its internal systems and controls were inadequate and caused the net deficit owed. The U.S. Attorney’s Office for the District of Arizona handled the case, and the U.S. Postal Inspection Service investigated.1U.S. Department of Justice. Plexus Worldwide LLC Agrees to Pay $600,000 to Resolve Alleged False Claims Violations
FDA Warning Letter on Supplement Health Claims
On July 30, 2014, the FDA issued a warning letter citing three Plexus products — Fast Relief, ProBio5, and BioCleanse — as unapproved “new drugs” because they were marketed as though they could cure or treat diseases.2Quackwatch. FDA Warning Letter About Plexus Products The agency pointed to website language promoting Fast Relief for nerve damage symptoms like pain and numbness, ProBio5 for jock itch and migraines, and BioCleanse for killing viruses and preventing conditions including the flu and chronic fatigue. The FDA also classified the products as misbranded for lacking adequate directions for use.
A company spokesman told the Arizona Republic that the offending marketing language was removed from the Plexus website after the letter.3AZCentral. Scottsdale Health Product Firm Cited for Misbranding
FTC Warnings and Penalty Offense Notices
On June 5, 2020, the FTC sent Plexus a warning letter as part of a broader crackdown on MLMs making coronavirus-related health claims.4FTC. Warning Letter to Plexus Worldwide, LLC The agency cited social media posts by Plexus representatives claiming supplements could “boost” the immune system against COVID-19, that specific probiotics were being used to “help treat COVID-19 symptoms,” and that an “EVERYDAY WELLNESS COMBO” could prevent the virus.5FTC. COVID-19 Warning Letter to Plexus Worldwide The FTC gave Plexus 48 hours to respond and reminded the company it is responsible for claims made by its business opportunity participants.6FTC. FTC Sends Second Round of Warning Letters to Multi-Level Marketers
The agency followed with two Notices of Penalty Offenses, which carry heavier legal weight than a warning letter. On October 26, 2021, Plexus received a Notice of Penalty Offenses Concerning Money-Making Opportunities, putting it on notice that misrepresenting typical earnings from its business opportunity is an unfair or deceptive practice under the FTC Act.7FTC. Penalty Offenses Concerning Money-Making Opportunities On April 13, 2023, the FTC issued a Notice of Penalty Offenses Concerning Substantiation, warning that health and efficacy claims must rest on competent scientific evidence and that any disease-treatment claim requires at least one randomized, double-blinded clinical trial.8Truth in Advertising. Plexus Worldwide Receiving these notices means the FTC treats Plexus as having actual knowledge that the listed practices are unlawful, which could expose the company to significant civil penalties if it violates them going forward.
California Lead Settlement Under Proposition 65
In 2015, the Environmental Research Center sued Plexus in Alameda County Superior Court under California’s Proposition 65, alleging that certain dietary supplements contained lead and that the company failed to provide legally required consumer warnings.9California Office of the Attorney General. 60-Day Notice: Environmental Research Center v. Plexus Worldwide The case settled in November 2016, with judgment entered in January 2017. Plexus paid $150,000 total: a civil penalty of roughly $20,800 and attorney fees and costs of about $129,200. The settlement permanently barred Plexus from selling covered products in California that expose users to more than 0.5 micrograms of lead per day without providing the mandated warnings.
Income Claim Findings and What Distributors Actually Earn
The way Plexus and its salesforce market the business opportunity has drawn repeated attention. Truth in Advertising began investigating in 2016 and identified more than 100 instances of distributors making atypical earnings claims on social media, promising luxury cars, expensive homes, and the ability to quit a day job, without the required disclosures about typical earnings.10PR Newswire. TINA.org Investigation Reveals What You Should Know About Plexus After the group contacted Plexus in February 2017 about deceptive claims in YouTube “documentaries,” the company removed more than 80 such videos from its channel.8Truth in Advertising. Plexus Worldwide TINA.org flagged similar issues again in 2024.
Plexus’s own 2024 U.S. Brand Ambassador compensation disclosure puts the average annual earnings for all ambassadors, active and inactive, at $742 before expenses. Among “active” ambassadors, those with a downline who earned commission in the prior six months, the average was $2,952 before expenses. The median earner in the top 10 percent made more than $1,203, and the median in the top one percent made more than $23,755.11Plexus Worldwide. 2024 United States Brand Ambassador Compensation Disclosure Statement
On February 7, 2025, the Direct Selling Self-Regulatory Council, run by BBB National Programs, decided Case #200-2025 and found that 17 social media posts by Plexus salesforce members overstated the income a typical participant could expect.12BBB National Programs. Administrative Closure – Plexus WorldWide, LLC Posts included claims of “full-time income,” earnings of “$500–$5,000 a month,” “financial freedom,” and the ability to earn a “substantial income” working two to three hours a day. Plexus had nine posts removed and eight others modified to strip the offending claims. The DSSRC administratively closed the case, citing the company’s “good faith actions,” and Plexus said it would continue enhancing compliance training for its sales force.
Plexus as Plaintiff: The Bravenly Global Suit
Not every Plexus lawsuit is against the company. On December 7, 2023, Plexus filed a complaint in the U.S. District Court for the Middle District of Florida against Bravenly Global, LLC and an individual named Aspen Emry, demanding a jury trial.13PACER Monitor. Plexus Worldwide LLC v. Bravenly Global LLC et al., Complaint It is one of several actions Plexus has brought against former distributors who moved to competing MLM companies. The public record covers only the initial filing; no resolution was identified in the available materials.
Consumer Complaints Over Auto-Renewals and Subscriptions
The Better Business Bureau’s profile for Plexus lists 44 complaints over a three-year period as of mid-2026, covering product issues, billing disputes, delivery problems, and service complaints.14BBB. Plexus Worldwide LLC BBB Complaints Some consumers have alleged unauthorized annual membership renewals, enrollment in monthly product subscriptions without consent, and difficulty canceling. The FTC has separately received more than 800 consumer complaints about Plexus, with more than 75 percent involving allegations that the company charged consumers repeatedly for unwanted product shipments.10PR Newswire. TINA.org Investigation Reveals What You Should Know About Plexus If you find recurring Plexus charges you did not authorize, keep those records; they mirror the pattern that has driven most of the federal complaint volume.